Nyxoah, a Belgian-Israeli start-up company that develops implants for treating sleep apnea and snoring, has been issued 11 patents for its technology.
The U.S. Patent and Trademark Office published the first eight granted patents for the technology for treating obstructive sleep apnea (OSA) on its website this week.
Nyxoah developed an ultrasmall implant that stimulates the tongue muscle to prevent airway blockage. In a short outpatient procedure, a flexible implant the size of a coin and thinner than a few sheets of paper is inserted under a patient's chin with a small, minimally invasive incision. Then, before going to sleep each night, the patient places a disposable adhesive battery patch on the underside of the chin, to wirelessly deliver energy to the nerves around the tongue throughout the night, preventing airway blockage during the night's sleep.
Nyxoah is a clinical-stage medical device start-up company focusing on neuromuscular electrical stimulation treatment of OSA.
